Biotage AB (publ) (BIOT.ST)
SEK 158.8
(1.73%)
SEK 158.8
(1.73%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.93 Billion SEK | 110.82% |
| 2022 | 2.33 Billion SEK | 17.42% |
| 2021 | 1.99 Billion SEK | 38.87% |
| 2020 | 1.43 Billion SEK | 7.39% |
| 2019 | 1.33 Billion SEK | 33.14% |
| 2018 | 1 Billion SEK | 32.49% |
| 2017 | 757.2 Million SEK | 8.92% |
| 2016 | 695.19 Million SEK | 3.94% |
| 2015 | 668.83 Million SEK | 8.05% |
| 2014 | 619.01 Million SEK | 4.52% |
| 2013 | 592.24 Million SEK | -9.45% |
| 2012 | 654.07 Million SEK | -6.43% |
| 2011 | 699.05 Million SEK | 0.81% |
| 2010 | 693.42 Million SEK | -43.5% |
| 2009 | 1.22 Billion SEK | -5.51% |
| 2008 | 1.29 Billion SEK | 31.4% |
| 2007 | 988.59 Million SEK | 7.78% |
| 2006 | 917.26 Million SEK | -5.9% |
| 2005 | 974.73 Million SEK | 40.22% |
| 2004 | 695.15 Million SEK | -15.91% |
| 2003 | 826.65 Million SEK | 21.92% |
| 2002 | 678.03 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.84 Billion SEK | -5.89% |
| 2024 Q1 | 5.14 Billion SEK | 4.38% |
| 2024 Q3 | 4.86 Billion SEK | 0.43% |
| 2023 Q3 | 5 Billion SEK | -0.02% |
| 2023 FY | 4.93 Billion SEK | 110.82% |
| 2023 Q4 | 4.93 Billion SEK | -1.4% |
| 2023 Q2 | 5 Billion SEK | 111.77% |
| 2023 Q1 | 2.36 Billion SEK | 0.98% |
| 2022 Q3 | 2.3 Billion SEK | 6.86% |
| 2022 Q4 | 2.33 Billion SEK | 1.43% |
| 2022 Q1 | 2.05 Billion SEK | 3.21% |
| 2022 FY | 2.33 Billion SEK | 17.42% |
| 2022 Q2 | 2.15 Billion SEK | 4.96% |
| 2021 Q3 | 1.5 Billion SEK | 6.62% |
| 2021 FY | 1.99 Billion SEK | 38.87% |
| 2021 Q1 | 1.57 Billion SEK | 9.86% |
| 2021 Q2 | 1.4 Billion SEK | -10.55% |
| 2021 Q4 | 1.99 Billion SEK | 32.53% |
| 2020 Q3 | 1.42 Billion SEK | 2.45% |
| 2020 Q2 | 1.38 Billion SEK | -2.9% |
| 2020 FY | 1.43 Billion SEK | 7.39% |
| 2020 Q1 | 1.42 Billion SEK | 6.9% |
| 2020 Q4 | 1.43 Billion SEK | 0.99% |
| 2019 Q2 | 1.27 Billion SEK | -0.56% |
| 2019 FY | 1.33 Billion SEK | 33.14% |
| 2019 Q4 | 1.33 Billion SEK | -0.48% |
| 2019 Q1 | 1.28 Billion SEK | 28.11% |
| 2019 Q3 | 1.34 Billion SEK | 5.01% |
| 2018 Q1 | 941.77 Million SEK | 24.38% |
| 2018 Q4 | 1 Billion SEK | 4.94% |
| 2018 FY | 1 Billion SEK | 32.49% |
| 2018 Q3 | 955.98 Million SEK | 4.43% |
| 2018 Q2 | 915.43 Million SEK | -2.8% |
| 2017 Q1 | 725.12 Million SEK | 4.3% |
| 2017 Q4 | 757.2 Million SEK | 8.24% |
| 2017 Q3 | 699.57 Million SEK | 3.88% |
| 2017 FY | 757.2 Million SEK | 8.92% |
| 2017 Q2 | 673.42 Million SEK | -7.13% |
| 2016 Q4 | 695.19 Million SEK | 5.62% |
| 2016 Q2 | 633.6 Million SEK | -7.48% |
| 2016 Q1 | 684.84 Million SEK | 2.39% |
| 2016 FY | 695.19 Million SEK | 3.94% |
| 2016 Q3 | 658.22 Million SEK | 3.89% |
| 2015 Q4 | 668.83 Million SEK | 4.9% |
| 2015 FY | 668.83 Million SEK | 8.05% |
| 2015 Q1 | 652.62 Million SEK | 5.43% |
| 2015 Q3 | 637.6 Million SEK | 3.46% |
| 2015 Q2 | 616.26 Million SEK | -5.57% |
| 2014 Q1 | 608.72 Million SEK | 2.78% |
| 2014 Q2 | 586.59 Million SEK | -3.63% |
| 2014 Q4 | 619.01 Million SEK | 2.55% |
| 2014 FY | 619.01 Million SEK | 4.52% |
| 2014 Q3 | 603.63 Million SEK | 2.9% |
| 2013 Q2 | 591.56 Million SEK | -7.51% |
| 2013 Q3 | 571.8 Million SEK | -3.34% |
| 2013 FY | 592.24 Million SEK | -9.45% |
| 2013 Q4 | 592.24 Million SEK | 3.58% |
| 2013 Q1 | 639.61 Million SEK | -2.21% |
| 2012 Q4 | 654.07 Million SEK | 0.34% |
| 2012 Q1 | 678.71 Million SEK | -2.91% |
| 2012 Q2 | 663.91 Million SEK | -2.18% |
| 2012 FY | 654.07 Million SEK | -6.43% |
| 2012 Q3 | 651.85 Million SEK | -1.82% |
| 2011 Q2 | 648.76 Million SEK | -4.22% |
| 2011 FY | 699.05 Million SEK | 0.81% |
| 2011 Q3 | 674.4 Million SEK | 3.95% |
| 2011 Q4 | 699.05 Million SEK | 3.65% |
| 2011 Q1 | 677.35 Million SEK | -2.32% |
| 2010 Q4 | 693.42 Million SEK | -37.94% |
| 2010 Q3 | 1.11 Billion SEK | -7.4% |
| 2010 Q2 | 1.2 Billion SEK | 2.83% |
| 2010 FY | 693.42 Million SEK | -43.5% |
| 2010 Q1 | 1.17 Billion SEK | -4.41% |
| 2009 Q4 | 1.22 Billion SEK | 0.0% |
| 2009 FY | 1.22 Billion SEK | -5.51% |
| 2008 FY | 1.29 Billion SEK | 31.4% |
| 2007 FY | 988.59 Million SEK | 7.78% |
| 2006 FY | 917.26 Million SEK | -5.9% |
| 2005 FY | 974.73 Million SEK | 40.22% |
| 2004 FY | 695.15 Million SEK | -15.91% |
| 2003 FY | 826.65 Million SEK | 21.92% |
| 2002 FY | 678.03 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| AddLife AB (publ) | 12.74 Billion SEK | 61.31% |
| Bonesupport Holding AB (publ) | 688.81 Million SEK | -615.866% |
| Doxa AB (publ) | 3.75 Billion SEK | -31.325% |
| Elekta AB (publ) | 31.41 Billion SEK | 84.303% |
| iZafe Group AB (publ) | 34.61 Million SEK | -14145.681% |
| Ortivus AB (publ) | 72.7 Million SEK | -6682.109% |
| Ortivus AB (publ) | 72.7 Million SEK | -6682.109% |
| Q-linea AB (publ) | 231.97 Million SEK | -2025.651% |
| S2Medical AB (publ) | 21.4 Million SEK | -22934.081% |
| Synsam AB (publ) | 8.03 Billion SEK | 38.639% |